These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group. Wexler HM, Finegold SM. J Chemother; 1991 Feb; 3 Suppl 2():12-9. PubMed ID: 2040893 [Abstract] [Full Text] [Related]
34. In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms. Jacobus NV, Cuchural GJ, Tally FP. J Antimicrob Chemother; 1989 Nov; 24(5):675-82. PubMed ID: 2599992 [Abstract] [Full Text] [Related]
35. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria]. Mittermayer H, Rotter M, Riezinger F, Thiel W, Stanek G. Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095 [Abstract] [Full Text] [Related]
38. Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins. White RL, Kays MB, Friedrich LV, Del Bene VE. J Antimicrob Chemother; 1993 Jan; 31(1):57-64. PubMed ID: 8444675 [Abstract] [Full Text] [Related]
39. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates. Aldridge KE, Sanders CV. J Clin Microbiol; 1987 Dec; 25(12):2317-21. PubMed ID: 3480894 [Abstract] [Full Text] [Related]
40. Sensitivity of Bacteroides fragilis to seven antimicrobial agents. Oitmaa M, Benn R. Pathology; 1981 Oct; 13(4):697-703. PubMed ID: 7335376 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]